HKI
NDC 62106-0625, Atropinum sulphuricum, Benzoicum acidum, Berberis vulgaris, Calcarea carbonica, Colocynthis, Coccus cacti, Lapis albus, Lithium carbonicum, Lycopodium clavatum, Oryctolagus cuniculus kidney, Rubia tinctorum, Sarsaparilla, Urtica urens, liquid, from Seroyal USA.
- Product NDC
- 62106-0625
- Status
- Listed
- Labeler
- Seroyal USA
- Dosage form
- LIQUID
- Route
- SUBLINGUAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62106-0625 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATROPINE SULFATE6 [hp_X]/30mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE12 [hp_X]/30mL
- CITRULLUS COLOCYNTHIS FRUIT PULP6 [hp_X]/30mL
- LYCOPODIUM CLAVATUM SPORE5 [hp_X]/30mL
- ORYCTOLAGUS CUNICULUS KIDNEY10 [hp_X]/30mL
- SARSAPARILLA1 [hp_X]/30mL
- CALCIUM HEXAFLUOROSILICATE12 [hp_C]/30mL
- BENZOIC ACID6 [hp_X]/30mL
- PROTORTONIA CACTI5 [hp_X]/30mL
- LITHIUM CARBONATE6 [hp_X]/30mL
- RUBIA TINCTORUM ROOT4 [hp_X]/30mL
- URTICA URENS1 [hp_X]/30mL
- BERBERIS VULGARIS ROOT BARK5 [hp_X]/30mL
Pharmacologic classes
Ammonium Ion Binding Activity [MoA]; Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]; Mood Stabilizer [EPC]; Nitrogen Binding Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62106-0625-0 | 62106062500 | 1 BOTTLE, GLASS in 1 CARTON (62106-0625-0) / 30 mL in 1 BOTTLE, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 62106-0625 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62106-0625 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62106-0625. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.